CSIMarket Company Name, Ticker, Competitors, else..
 
Precipio inc   (NASDAQ: PRPO)
 
Price: $26.1200 $-1.38 -5.018%
Day's High: $27.8700008392334 Week Perf: -9.46 %
Day's Low: $ 25.91 30 Day Perf: 11.24 %
Volume (M): 423,761 52 Wk High: $ 33.63
Volume (M$): $ 0 52 Wk Avg: $23.93
Open: $27.67 52 Wk Low: $16.00



 Market Capitalization (Millions $) 47
 Shares Outstanding (Millions) 2
 Employees 71
 Revenues (TTM) (Millions $) 27
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Business Description


Precipio Inc. is a healthcare company that principally operates in the United States. The company focuses on providing diagnostic services and products for the oncology field. Precipio offers a range of services including molecular diagnostics, liquid biopsy, and cytogenetics. They utilize advanced technologies and techniques to provide accurate and precise diagnoses to healthcare providers and patients. Precipio's mission is to improve patient outcomes by delivering high-quality diagnostic solutions for cancer-related conditions.


   Company Address: 4 Science Park New Haven 6511 CT
   Company Phone Number: 787-7888   Stock Exchange / Ticker: NASDAQ PRPO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GH   -4.44%    
MYGN        1.57% 
VCYT   -1.28%    
• View Complete Report
   



Contract

Precipio Terminates ATM Management Decision to Reinforce Commitment to Responsible Capital Management

Published Tue, Sep 2 2025 2:10 PM UTC

In a significant move reflecting its strategic financial approach, Precipio Inc. announced the termination of its Automated Teller Machine (ATM) management decision. This decision is aligned with the company’s commitment to responsible capital management, reinforcing its dedication to maintaining a robust financial framework amidst a challenging economic landscape.Precipio...
Shares

Precipios Bold Shift in Executive Compensation: Performance-Driven Awards Redefine Industry Standards

Published Thu, Jan 16 2025 10:00 PM UTC

In a notable departure from traditional equity compensation structures, Precipio Inc. has announced a strategic shift in how they incentivize senior management. In a press release dated October 8, 2024, the company revealed that it will now grant performance-based awards linked to the stock price instead of traditional, time-vested Employee Stock Option Plans (ESOPs). This i...
Product Service News

Precipios Innovative Advances in Cancer Diagnostics Set a New Standard for Patient Care

Published Tue, Oct 8 2024 2:00 PM UTC

As the landscape of cancer diagnostics continues to evolve, Precipio, Inc. has positioned itself at the forefront of innovative testing solutions. The company, known for its specialty diagnostics focused on hematologic cancers, recently announced the expansion of its Bloodhound MPN panel to include CALR mutation subtyping. This development promises significant enhancements i...
Stock Market Announcement

Precipio Announces Employee Stock Option Plan Repricing: A Strategic Move to Drive Value for Employees and Shareholders,

Published Fri, Sep 6 2024 8:00 PM UTC

Precipio Announces Employee Stock Option Plan Repricing: Analysis and Impact on Shareholders
On (date), Precipio Inc. announced the repricing of their Employee Stock Option Plan, outlining the rationale behind this decision and detailing its potential impact on shareholders. With a total of 1.463543 million shares outstanding and a current price per share of $6.3, this m...
Stock Market Announcement

ABC Corporation Set to Make Waves at Rescheduled Shareholders Meeting on June 21

Published Thu, Jun 13 2024 8:00 PM UTC

The highly anticipated shareholders meeting for ABC Corporation has been rescheduled to Friday, June 21 at 9 a.m. Eastern Time. This meeting promises to be a significant event for the company and its investors, as important decisions are set to be made.
The rescheduling of the meeting has generated much speculation and anticipation among shareholders and industry analyst...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.72
Price to Sales (Expected) -
Price to Book 3.16
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.83
Working Capital Ratio 1.77
Leverage Ratio (MRQ) 0.44
Total Debt to Equity 0.06
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.65 $
Revenues (TTM) 15.22 $
Cash Flow (TTM) 0.82 $
Cash 1.72 $
Book Value 8.26 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 383,070
Net Income per Employee (TTM) -17,113
Receivable Turnover Ratio (TTM) 13.25
Inventory Turnover Ratio (TTM) 18.05
Asset Turnover Ratio (TTM) 1.29

Profitability Ratios Current
Gross Margin (MRQ) 44.67 %
Operating Margin (MRQ) -8.53 %
Net Margin (MRQ) -3.12 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Precipio Inc's Segments
Service revenue net    173.29 % of total Revenue
Product    22.29 % of total Revenue
Diagnostic Testing    176.86 % of total Revenue
Single reportable segment    195.58 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.